Pharmacokinetic (Pk) And Pharmacodynamic (Pd) Results Of A Novel, First-In-Class Modulator Of Eukaryotic Translation Initiation Factor 5a (Eif5a) In Patients (Pts) With Relapsed Or Refractory B-Cell Malignancies: Data From A Phase 1-2 Study

BLOOD(2014)

引用 23|浏览20
暂无评分
摘要
Introduction
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要